Monday 03 Oct 2016 @ 13:20
Competition & Markets Authority
Printable version

CMA consults on Celesio/Sainsbury’s merger undertakings

The CMA is consulting on undertakings from Celesio to sell some Sainsbury’s UK pharmacies.

On 29 July 2016, the Competition and Markets Authority (CMA) announced that Celesio will have to sell a Lloyds pharmacy in each of the 12 local areas in which it had found a significant lessening of competition to a new owner, to be approved by the CMA, to maintain the current level of competition for local customers in those areas. Celesio is not permitted to close its pharmacies in those areas.

Celesio and its subsidiary Lloyds Pharmacy Limited have now offered undertakings to sell the required number of pharmacies to one or more suitable buyer(s) to be approved by the CMA. The CMA now invites written comments from interested parties.

Anyone wishing to respond to the CMA consultation should do so in writing, by no later than 5 pm on 15 October 2016 to celesio.sainsburys@cma.gsi.gov.uk or write to:

Remedies Manager
Celesio/Sainsbury’s Merger Inquiry
Competition and Markets Authority
Victoria House
Southampton Row
London
WC1B 4AD

The notice of proposal to accept final undertakings and all other information relating to this investigation can be found on the case page.

 

Channel website: https://www.gov.uk/government/organisations/competition-and-markets-authority

Share this article

Latest News from
Competition & Markets Authority

CMA outlines growing concerns in markets for AI Foundation Models

11/04/2024 16:25:00

The CMA has outlined 3 key risks to effective competition on AI Foundation Models and has set out plans for further action in the market.

CMA wins second legal challenge in Cérélia/Jus-Rol case

11/04/2024 13:10:00

The Court of Appeal has fully dismissed a legal challenge from Cérélia, and upheld the Competition Appeal Tribunal’s finding that the CMA was ‘rational and fair’ in its merger review.

Pharma deal could reduce choice and lead to higher prices for HRT treatments

04/04/2024 14:20:00

Following its Phase 1 investigation, the CMA has found that Theramex's proposed purchase of Femoston and Duphaston could reduce competition and choice for hormone replacement therapy treatments.

Spread betting deal raises competition concerns

04/04/2024 12:20:00

The deal seeks to combine the only 2 licensed sports spread betting operators in the UK market.

High fuel margins ‘concerning’ CMA finds

28/03/2024 16:15:00

The CMA’s latest monitoring report on road fuel shows that prices at the pump have risen since late January, accompanied by above average margins and spreads.

High fuel margins ‘concerning’ CMA finds

28/03/2024 12:20:00

The CMA’s latest monitoring report on road fuel shows that prices at the pump have risen since late January, accompanied by above average margins and spreads.

Green claims: CMA secures landmark changes from ASOS, Boohoo and Asda

27/03/2024 12:05:00

Following CMA action, millions of consumers can now expect to see accurate and clear green claims when shopping for fashion items with ASOS, Boohoo and George at Asda.

Vodafone / Three deal could leave consumers and businesses worse off

22/03/2024 16:20:00

The deal, which seeks to combine 2 of the 4 UK mobile network operators, could lead to higher prices for customers and affect investment in UK mobile networks.

UK businesses continue to adapt to changes in UK internal market

20/03/2024 16:10:00

OIM report suggests trade between UK nations is not a challenge for most, while policy design can minimise disruption.